{"id":"https://openalex.org/W2914511474","doi":"https://doi.org/10.1182/blood-2018-99-118978","title":"Pharmacodynamical Modeling of Two-Way Synergistic Effect for High-Throughput Drug Combination Screening in an Ex Vivo Reconstruction of Bone Marrow Using Primary Multiple Myeloma Cells","display_name":"Pharmacodynamical Modeling of Two-Way Synergistic Effect for High-Throughput Drug Combination Screening in an Ex Vivo Reconstruction of Bone Marrow Using Primary Multiple Myeloma Cells","publication_year":2018,"publication_date":"2018-11-29","ids":{"openalex":"https://openalex.org/W2914511474","doi":"https://doi.org/10.1182/blood-2018-99-118978","mag":"2914511474"},"language":"en","primary_location":{"id":"doi:10.1182/blood-2018-99-118978","doi":"https://doi.org/10.1182/blood-2018-99-118978","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood-2018-99-118978","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5012307401","display_name":"Praneeth Reddy Sudalagunta","orcid":"https://orcid.org/0000-0003-1283-9332","observed_orcids":["https://orcid.org/0000-0003-1283-9332"]},"institutions":[{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Praneeth Reddy Sudalagunta","raw_affiliation_strings":["Cancer Physiology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cancer Physiology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL","institution_ids":["https://openalex.org/I3019308854"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060845150","display_name":"Rafael Renatino Canevarolo","orcid":"https://orcid.org/0000-0002-8722-8512","observed_orcids":["https://orcid.org/0000-0002-8722-8512"]},"institutions":[{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Rafael Renatino Canevarolo","raw_affiliation_strings":["Cancer Physiology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cancer Physiology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL","institution_ids":["https://openalex.org/I3019308854"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Maria D Coelho Siqueira Silva","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Maria D Coelho Siqueira Silva","raw_affiliation_strings":["Cancer Physiology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cancer Physiology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL","institution_ids":["https://openalex.org/I3019308854"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5014350127","display_name":"Mark B. Meads","orcid":"https://orcid.org/0009-0008-0259-1875","observed_orcids":["https://orcid.org/0009-0008-0259-1875"]},"institutions":[{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Mark B. Meads","raw_affiliation_strings":["Department of Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL","institution_ids":["https://openalex.org/I3019308854"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5076405628","display_name":"Alex Tungesvik","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2613432","display_name":"University of South Florida","ror":"https://ror.org/032db5x82","country_code":"US","type":"education","lineage":["https://openalex.org/I2613432"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Alex Tungesvik","raw_affiliation_strings":["University of South Florida, Tampa, FL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of South Florida, Tampa, FL","institution_ids":["https://openalex.org/I2613432"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5035860017","display_name":"Gabriel De Avila","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Gabriel De Avila","raw_affiliation_strings":["Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL","institution_ids":["https://openalex.org/I3019308854"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053572690","display_name":"Kenneth H. Shain","orcid":"https://orcid.org/0000-0003-4178-8888","observed_orcids":["https://orcid.org/0000-0003-4178-8888"]},"institutions":[{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kenneth H. Shain","raw_affiliation_strings":["Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL","institution_ids":["https://openalex.org/I3019308854"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5070118399","display_name":"Ariosto Siqueira Silva","orcid":"https://orcid.org/0000-0003-3237-9986","observed_orcids":["https://orcid.org/0000-0003-3237-9986"]},"institutions":[{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Ariosto Siqueira Silva","raw_affiliation_strings":["Cancer Physiology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cancer Physiology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL","institution_ids":["https://openalex.org/I3019308854"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5012307401","https://openalex.org/A5014350127","https://openalex.org/A5035860017","https://openalex.org/A5060845150","https://openalex.org/A5070118399","https://openalex.org/A5076405628"],"corresponding_institution_ids":["https://openalex.org/I2613432","https://openalex.org/I3019308854"],"apc_list":{"value":5500,"currency":"USD","value_usd":5500},"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"132","issue":"Supplement 1","first_page":"1919","last_page":"1919"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10649","display_name":"Multiple Myeloma Research and Treatments","score":0.9932000041007996,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10649","display_name":"Multiple Myeloma Research and Treatments","score":0.9932000041007996,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11829","display_name":"Mathematical Biology Tumor Growth","score":0.00139999995008111,"subfield":{"id":"https://openalex.org/subfields/2611","display_name":"Modeling and Simulation"},"field":{"id":"https://openalex.org/fields/26","display_name":"Mathematics"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T11235","display_name":"Statistical Methods in Clinical Trials","score":0.0010000000474974513,"subfield":{"id":"https://openalex.org/subfields/2613","display_name":"Statistics and Probability"},"field":{"id":"https://openalex.org/fields/26","display_name":"Mathematics"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/multiple-myeloma","display_name":"multiple myeloma","score":0.996999979019165},{"id":"https://openalex.org/keywords/drug-synergy","display_name":"drug synergy","score":0.7279999852180481},{"id":"https://openalex.org/keywords/pharmacodynamics","display_name":"pharmacodynamics","score":0.6600000262260437},{"id":"https://openalex.org/keywords/carfilzomib","display_name":"carfilzomib","score":0.8539999723434448},{"id":"https://openalex.org/keywords/dexamethasone","display_name":"dexamethasone","score":0.9990000128746033},{"id":"https://openalex.org/keywords/drug-resistance","display_name":"drug resistance","score":0.4350000023841858},{"id":"https://openalex.org/keywords/tumor-microenvironment","display_name":"tumor microenvironment","score":0.5509999990463257},{"id":"https://openalex.org/keywords/stromal-cell-co-culture","display_name":"stromal co-culture","score":0.6639999747276306},{"id":"https://openalex.org/keywords/ld50","display_name":"LD50","score":0.40400001406669617},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.4519999921321869}],"concepts":[{"id":"https://openalex.org/C26291073","wikidata":"https://www.wikidata.org/wiki/Q310484","display_name":"Ex vivo","level":3,"score":0.7935208082199097},{"id":"https://openalex.org/C2776364478","wikidata":"https://www.wikidata.org/wiki/Q467635","display_name":"Multiple myeloma","level":2,"score":0.6997124552726746},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.6440442800521851},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5916144847869873},{"id":"https://openalex.org/C2780007613","wikidata":"https://www.wikidata.org/wiki/Q546523","display_name":"Bone marrow","level":2,"score":0.5351705551147461},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.46869468688964844},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.41673222184181213},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.38879093527793884},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.34951841831207275},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.337337851524353},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.2584592401981354},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.21651893854141235},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.17070826888084412},{"id":"https://openalex.org/C150903083","wikidata":"https://www.wikidata.org/wiki/Q7108","display_name":"Biotechnology","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1182/blood-2018-99-118978","doi":"https://doi.org/10.1182/blood-2018-99-118978","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood-2018-99-118978","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.979200005531311}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W3014344094","https://openalex.org/W2609004154","https://openalex.org/W4211003428","https://openalex.org/W2140930481","https://openalex.org/W6889024590","https://openalex.org/W3212137534","https://openalex.org/W4220851771","https://openalex.org/W2605974076","https://openalex.org/W904214523","https://openalex.org/W2277710605"],"abstract_inverted_index":{"Abstract":[0],"Introduction:":[1],"Innate":[2],"and":[3,33,81,96,168,204,231,294,307,332,343,510,522,579,630],"acquired":[4],"resistance":[5],"to":[6,42,46,136,189,202,211,223,284,303,416,455,463,483,554,620,640],"anti-cancer":[7],"therapies":[8,28],"poses":[9],"a":[10,55,91,100,195,249,349,361,366,373,388,446,456,488,501,519,533,613,628,632],"major":[11],"hurdle":[12],"in":[13,36,40,48,89,108,156,165,318,352,394,397,414,421,438,448,459,468,494,515],"effectively":[14],"treating":[15],"many":[16],"cancers,":[17],"especially":[18],"an":[19,86,109,130,157,208],"incurable":[20],"cancer":[21],"like":[22],"multiple":[23,120,264],"myeloma":[24,121,265],"(MM).":[25],"Rational":[26],"combination":[27,49,59,106,138,226,295,333,341,512,557,580,610,626],"have":[29,539],"shown":[30],"improved":[31],"efficacy":[32],"reduced":[34],"toxicity":[35],"MM.":[37],"Patient":[38],"variability":[39,47],"response":[41,67,140,199,247,280,466,486,499,558],"single":[43,285,324,507,565,577],"agents":[44],"leads":[45],"effects,":[50],"which":[51],"require":[52],"quantification":[53,61],"on":[54,64],"patient-to-patient":[56],"basis.":[57],"Conventional":[58],"effect":[60,107,413,419,424,458,531],"methods":[62],"rely":[63],"dose":[65,203],"-":[66,288,297],"curves":[68,311,316],"obtained":[69,128,238],"from":[70,129,149,239,313,479,593,602],"experiments":[71],"involving":[72],"cell":[73],"lines.":[74],"Such":[75,194],"studies":[76],"don't":[77],"account":[78],"for":[79,180,335,411,427,505,622,627],"intratumoral":[80],"intertumoral":[82],"heterogeneity":[83],"that":[84,102,537,616],"play":[85],"important":[87],"factor":[88],"driving":[90],"patient's":[92],"clinical":[93,241,481],"response.":[94,528],"Materials":[95],"Methods:":[97],"We":[98],"propose":[99],"framework":[101,124,607],"captures":[103,608],"tumor-specific":[104],"two-way":[105],"ex":[110,131,158,270,278,471],"vivo":[111,132,159,271,279,290,472],"reconstruction":[112],"of":[113,262,330,406,425,443,562,587,599,638],"the":[114,126,225,243,310,314,328,340,378,385,392,399,402,407,417,465,470,506,511,523,527,556,560,563,570,574,588,594,597,623],"tumor":[115],"microenvironment":[116],"using":[117,142,612],"patient-derived":[118],"primary":[119],"cells.":[122,193],"The":[123,276,321,423,497,582,605],"translates":[125],"data":[127,237,281,478],"drug":[133],"sensitivity":[134],"assay":[135],"patient-specific":[137,246,609],"therapy":[139],"predictions":[141,584],"mathematical":[143,219,301],"modeling.":[144],"MM":[145],"cells":[146],"(CD138+)":[147],"extracted":[148],"fresh":[150],"bone":[151],"marrow":[152],"aspirates":[153],"are":[154,346,474,513],"seeded":[155],"co-culture":[160],"model":[161,220,244,551,583,615],"with":[162,170,200,234,272,339,476,559],"human":[163],"stroma":[164],"multi-well":[166],"plates,":[167],"tested":[169,269,338],"various":[171],"drugs/combinations":[172],"at":[173,181],"several":[174],"concentrations.":[175],"Each":[176],"well":[177],"is":[178,221,282,396,532],"imaged":[179],"least":[182],"96":[183,322],"hours,":[184],"once":[185],"every":[186],"30":[187],"minutes":[188],"estimate":[190,304],"percent":[191],"viable":[192],"platform":[196],"facilitates":[197],"measuring":[198],"respect":[201],"time,":[205],"making":[206],"this":[207],"ideal":[209],"paradigm":[210],"capture":[212],"pharmacodynamical":[213],"interactions":[214],"between":[215,228],"drugs.":[216],"An":[217],"empirical":[218],"used":[222,619],"measure":[224],"effects":[227,611],"two":[229,564],"drugs,":[230],"when":[232],"combined":[233],"their":[235],"pharmacokinetic":[236,477],"Phase-I":[240,480],"trials":[242,482],"predicts":[245],"over":[248,368,487,500],"90":[250,489,502],"day":[251,490,503],"treatment":[252,491],"period":[253,492,504],"within":[254],"five":[255],"days":[256],"post":[257],"biopsy.":[258],"Results:":[259],"A":[260,356,546],"total":[261],"58":[263],"patient":[266,362,629],"samples":[267],"were":[268],"19":[273,336,589],"two-drug":[274],"combinations.":[275],"resulting":[277],"fit":[283],"agent":[286,578],"(EMMA":[287],"Ex":[289],"Mathematical":[291],"Myeloma":[292],"Advisor)":[293],"(SAM":[296],"Synergy":[298],"Augmented":[299],"Model)":[300],"models":[302,473],"patient-drug/combination-specific":[305],"LD50s":[306,334],"area":[308],"under":[309,401],"(AUCs)":[312],"dose-time-response":[315,403],"(shown":[317,493],"Figs.":[319,439,495],"1a-f).":[320],"hour":[323],"agent,":[325],"additive":[326,369,530],"(in":[327],"sense":[329],"Bliss),":[331],"patients":[337,590],"Carfilzomib":[342],"Dexamethasone":[344],"(CFZ+DEX)":[345],"presented":[347,514],"as":[348,387,436,518],"box":[350,389,520,571],"plot":[351,521,572],"Fig.":[353,382,516],"2a":[354],".":[355],"red":[357],"dashed":[358,375],"line":[359,376],"signifies":[360],"who":[363],"would":[364,552,591],"see":[365],"benefit":[367,592,600],"LD50":[370,435,449],"(synergism),":[371],"while":[372],"blue":[374],"implies":[377],"opposite":[379],"(antagonism).":[380],"Similarly,":[381],"2b":[383],"presents":[384,569],"AUCs":[386],"plot,":[390],"where":[391],"\"area\"":[393],"AUC":[395,430,451],"fact":[398],"volume":[400],"curve.":[404],"Inclusion":[405],"time":[408],"axis":[409],"accounts":[410],"exposure-response":[412],"addition":[415],"dose-response":[418],"captured":[420],"LD50.":[422],"accounting":[426],"exposure":[428],"via":[429],"suggests":[431],"greater":[432],"synergy":[433],"than":[434],"seen":[437],"2a-b.":[440],"In":[441,461],"spite":[442],"being":[444],"insightful,":[445],"decrease":[447],"and/or":[450],"doesn't":[452],"always":[453],"translate":[454],"synergistic":[457],"patients.":[460],"order":[462],"predict":[464],"observed":[467],"patients,":[469],"integrated":[475],"simulate":[484],"patients'":[485],"1j-l).":[496],"best":[498,576],"agents,":[508],"additive,":[509],"2c":[517],"right":[524],"y-axis":[525],"classifies":[526],"However,":[529],"theoretically":[534],"computed":[535],"quantity":[536],"may":[538],"pharmacological":[540],"relevance":[541],"but":[542],"isn't":[543],"significant":[544],"clinically.":[545],"more":[547],"clinically":[548],"relevant":[549,636],"reference":[550],"be":[553,618],"compare":[555],"better":[561],"agents.":[566],"Figure":[567],"2d":[568],"comparing":[573],"predicted":[575],"responses.":[581],"indicate":[585],"all":[586],"combination,":[595],"although":[596],"extent":[598],"varies":[601],"patient-to-patient.":[603],"Conclusion:":[604],"proposed":[606],"pharmacodynamic":[614],"can":[617],"screen":[621],"most":[624],"efficacious":[625],"across":[631],"cohort.":[633],"Disclosures":[634],"No":[635],"conflicts":[637],"interest":[639],"declare.":[641]},"counts_by_year":[{"year":2020,"cited_by_count":1}],"updated_date":"2026-10-08T09:06:37.294493","created_date":"2019-02-21T00:00:00"}